Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Abstract Background Inflammatory breast cancer (IBC) is a rare and rapidly progressive form of invasive breast cancer. The aim of this study was to explore the clinical evolution, stromal tumour-infiltrating lymphocytes (sTIL) infiltration and programmed death-ligand 1 (PD-L1) expression in a large...

Full description

Bibliographic Details
Main Authors: C. Van Berckelaer, C. Rypens, P. van Dam, L. Pouillon, M. Parizel, K. A. Schats, M. Kockx, W. A. A. Tjalma, P. Vermeulen, S. van Laere, F. Bertucci, C. Colpaert, L. Dirix
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Breast Cancer Research
Subjects:
Inflammatory breast cancer (IBC)
Immune response
Programmed death-ligand 1 (PD-L1)
Stromal tumour-infiltrating lymphocytes (sTIL)
Immune checkpoint modulators
Online Access:http://link.springer.com/article/10.1186/s13058-019-1108-1

Internet

http://link.springer.com/article/10.1186/s13058-019-1108-1

Similar Items